The disclosure relates to method, apparatus and system to detect flowrate in a microfluidic system. In one embodiment, the disclosure relates to a method, apparatus and system to detect particle flowrate in a microfluidic system with fluidic channels in the range of about 0.1 micro-liter per minute (μL/min) to 10 milli-liter per minute (mL/min). The disclosed embodiments may be used to detect movement of components in biological samples such as tumor cells (e.g., circulating tumor cells) through a fluidic circuit.
Biological samples from a subject often contain a large number of different components. For example, a sample of a subject's blood may contain free floating DNA and RNA, circulating cells, and many other components. The number and diversity of such components in a biological sample often complicates or prevents the accurate identification and/or quantification of specific components of interest within the sample, which would enable the diagnosis or monitoring of a condition in the subject, such as cancer.
For instance, circulating tumor cells (CTCs) are cells shed from tumors that enter into a subject's blood stream. Once in the blood, these cells can circulate through the subject's body, where they can invade other tissues and grow new tumors. CTCs are thus implicated in metastasis, which is the primary cause of death in subjects with cancer. Efforts to count CTCs have been hampered by the fact that CTCs are extremely difficult to detect. They are exceptionally rare, and may be difficult to distinguish from healthy cells. Current approaches for detecting CTCs rely on immunoassays, in which antibodies are used to target specific biomarkers on the surfaces of the CTCs. However, such approaches have limitations in sensitivity and/or specificity, leading to many healthy cells being mischaracterized as cancerous, and many cancer cells being missed in the analysis.
There is a need to identify and measure movement of biological components (e.g., particles) through a fluidic circuit used for cell testing and identification. Such measurement can inform other valuable information, for example, it can identify obstruction in a fluidic circuit. The fluidic flow in such system is exceptionally slow (low-flow rate) and the conventional systems do not provide a meaningful measure of particle movement in such systems that does not expose (i.e., contact-less) the particle.
Methods, system and apparatus for detecting component flowrate in microfluidic circuits are disclosed. In certain aspects, the methods may be used to detect and/or quantify specific component (e.g., particles) flowrate in a biological sample in a closed microfluidic system. The component may comprise tumor cells (e.g., circulating tumor cells, or CTCs), chemicals, droplets, particulate entities, molecules and the like. Systems and devices for use in practicing methods of the invention are also provided.
In one embodiment, the disclosure relates to method, apparatus and system to detect flowrate in a microfluidic system. An exemplary method to detect flowrate of a low-flow constituent in a fluidic circuit includes the steps of: (1) pneumatically driving a first fluid into the fluidic circuit, the first fluid including a first reagent, a first detection component and the constituent; (2) defining a sampling area in the fluidic circuit and exposing a microchannel in the sampling area to a wavelength configured to excite the first detection component to thereby provide a detection emission from the first detection component of the first reagent; (3) filtering the detection emission from the first reagent at an optical filer to substantially isolate a detection emission frequency; (4) determining flowrate of the constituent through the microchannel as a function of the isolated detection emission frequency. The flowrate of the constituent through the microchannel can be measured relevant to the flowrate of the first detection component through the microchannel. In certain embodiments, the first detection component comprises a fluorescent dye.
In another embodiment, the disclosure relates to a system to detect flowrate of a low-flow constituent in a fluidic circuit. An exemplary system comprises: a cartridge having one or more fluidic reservoirs and a sampling area wherein: the one or more one or more fluidic reservoirs are configured to receive a first fluid, the first fluid including a first reagent, a first detection component and the constituent; the sampling area positioned relative to the one or more fluidic reservoirs and having a microchannel, the microchannel exposable to an incoming excitation radiation and emitting at least one excitation signal when one of the first detection component is excited; a power source to pneumatically drive the first fluid from the one or more fluidic reservoirs to the microchannel; an illuminate source to illuminate the sampling area with a wavelength configured to excite the first detection component to thereby provide a detection emission from the first detection component; an optical filter to filter the detection emission from to substantially isolate a detection emission frequency; and a processor to receive the substantially isolated detection emission frequency and to determine flowrate of the constituent through the microchannel as a function of the isolated detection emission frequency. The flowrate of the constituent through the microchannel can be measured relevant to the flowrate of the first detection component through the microchannel. The detection component may include one or more fluorescent dyes or other chemicals that can be excited to emit a known-signature radiation.
In some embodiment, the flowrate of the low-flow constituent is in the range of about 0.1 μL/min to about 1 mL/min. In some embodiments, the flowrate of the low-flow constituent is equal or less than 1 μL/min. In one embodiment, the flow rate is about 0.1 μL/min.
An exemplary system according to one embodiment is contact-less. That is, a pneumatic power source drives the fluid into the reservoirs or from the reservoirs into one or more microchannels. Further, an illumination source illuminates a detection component (e.g., a fluorescent dye). Emissions from the illuminated detection component are received from the sampling area and used to track movement of the dye through the sampling area.
In certain embodiments, flow rates of two detection components are measured simultaneously and two flowrates are determined relative to each other. In one implementation a microprocessor circuitry measures flowrate of the second detection component through one or more microchannels to determine a relative movement of the first and the second detection components through the microchannel.
The detection system may include a memory circuitry to store information or instructions. The instructions may be executed on a microprocessor circuitry. The microprocessor circuitry may be in communication with the pneumatic driving mechanism to control fluidic flow through the microchannel. The microprocessor may also be in communication with the illumination source used to activate the detection component. The microprocessor may be in communication with an optical filter system that received radiation emissions from the detection component once the detection component is optically activated by the illumination source. The microprocessor can identify movement or placement of the detection component in the microchannel during a period of time to thereby calculate movement of the low-flow constituent in the microchannel. Thus, an exemplary system can measure flowrate of a low-flow constituent in a microchannel without contacting the constituent or its fluidic carrier.
In some embodiments, the flowrate of the constituent is used to determine movement of a discrete particle, an entity, a cell or a droplet through one or more microchannels.
In still another embodiment, the determined flowrate is compared to a threshold value to identify an obstructed microchannel. In another embodiment, the determined flowrate is compared to a threshold value to identify internal pressure in the microchannel.
The invention may be best understood from the following detailed description when read in conjunction with the accompanying drawings in which like elements are numbered similarly and where:
Methods for the detection of components from biological samples are provided. In certain aspects, the methods may be used to detect and/or quantify specific components in a biological sample, such as tumor cells (e.g., circulating tumor cells). Systems and devices for use in practicing methods of the invention are also provided.
The subject methods and devices may find use in a wide variety of applications, such as the detection of cancer, detection of aneuploidy from DNA circulating in a mother's blood stream, monitoring disease progression, analyzing the DNA or RNA content of cells, and a variety of other applications in which it is desired to detect and/or quantify specific components in a biological sample.
During the PCR reaction, if a droplet contains a genome of a cell with a mutation for which the primer(s) are designed to detect, amplification is initiated (step 110). The presence of a particular PCR product(s) may be detected by, for example, a fluorescent output that turns the drop fluorescent (step 112). The drops may thus be scanned (e.g., using flow cytometry) to detect the presence of fluorescently-tagged drops. The drops may also be sorted (step 114) using, for example, droplet sorting to recover drops of interest. The steps described above are conventionally performed under microfluidic control and with one or more microfluidics devices.
The fluidic reservoirs are configured to receive reagents which can be used for automated testing, for example, as described in steps 102-106 of
A flow detection region (interchangeably, sampling area) 232 is formed in cartridge 232. The location of detection region 232 in
Sampling area 232 may receive fluorescent excitation as indicated by arrow 234. Conventional fluorescent excitation source may be used for this purpose. Reagents having fluorescent tags will emit fluorescent light upon receiving excitation rays 234. A detector (not shown) receives fluorescent emission 236 and can measure reagent movement in microchannel 240 of flow detection region 232.
Various ways of detecting the absence or presence of PCR products has been conventionally employed in which a variety of different detection components are used. Detection components of interest may include, among others, fluorescein and its derivatives; rhodamine and its derivatives; cyanine and its derivatives; coumarin and its derivatives; Cascade Blue and its derivatives; Lucifer Yellow and its derivatives; BODIPY and its derivatives; and the like. Exemplary fluorophores include indocarbocyanine (C3), indodicarbocyanine (C5), Cy3, Cy3.5, Cy5, Cy5.5, Cy7, Texas Red, Pacific Blue, Oregon Green 488, Alexa fluor-355, Alexa Fluor 488, Alexa Fluor 532, Alexa Fluor 546, Alexa Fluor-555, Alexa Fluor 568, Alexa Fluor 594, Alexa Fluor 647, Alexa Fluor 660, Alexa Fluor 680, JOE, Lissamine, Rhodamine Green, BODIPY, fluorescein isothiocyanate (FITC), carboxy-fluorescein (FAM), phycoerythrin, rhodamine, dichlororhodamine (dRhodamine), carboxy tetramethylrhodamine (TAMRA), carboxy-X-rhodamine (ROX), LIZ, VIC, NED, PET, SYBR, PicoGreen, RiboGreen, and the like. Detection components may include beads (e.g., magnetic or fluorescent beads, such as Luminex beads) and the like. Detection may involve holding a microdroplet at a fixed position during thermal cycling so it can be repeatedly imaged. In certain aspects, detection may involve fixing and/or permeabilizing one or more cells in one or more microdroplets.
Referring again to
Cartridge 310 includes flow detection area (sampling area) 332 which includes one or more microfluidic channels (not shown). Flow detection region 332 is configured to receive fluorescence excitation rays as indicated by arrow 334. Fluorescence emission rays 336 are generated from detection component(s) included in the reagent flowing through the microchannel 341.
The reagent flow through cartridge 310 is illustrated by arrows 323, 325 and 327. In one implementation, pneumatic pressure causes movement of reagent 321 through reservoir 320 and into the microchannel 341 as indicated by arrows 323 and 325. In one embodiment of the disclosure, the reagent flow through microchannel 341 is equal or less than 1 μL/min. In another embodiment, the reagent flow through microchannel 341 is equal or less than 1 μL/min. During reagent flow through microchannel 340, an excitation source illuminates 334 detection components. The detection components emit excitation rays 236. The emission is detected via one or more detection systems (not shown). The effluent of microchannel 340 is collected at collection tube 360 as indicated by arrow 327.
Suitable subjects include those who have and those who have not been diagnosed with a condition, such as cancer. Suitable subjects include those that are and are not displaying clinical presentations of one or more cancers. In certain aspects, a subject may one that may be at risk of developing cancer, due to one or more factors such as family history, chemical and/or environmental exposure, genetic mutation(s) (e.g., BRCA1 and/or BRCA2 mutation), hormones, infectious agents, radiation exposure, lifestyle (e.g., diet and/or smoking), presence of one or more other disease conditions, and the like. A variety of different types of biological samples may be obtained from such subjects. In certain embodiments, whole blood is extracted from a subject. Whole blood may be treated prior to practicing the subject methods, such as by centrifugation, fractionation, purification, and the like. The volume of the whole blood sample that is extracted from a subject may be 100 mL or less, e.g., about 100 mL or less, about 50 mL or less, about 30 mL or less, about 15 mL or less, about 10 mL or less, about 5 mL or less, or about 1 mL or less.
The subject methods and devices provided herein are compatible with both fixed and live cells. In certain embodiments, the subject methods and devices are practiced with live cells. In other embodiments, the subject methods and devices are practiced with fixed cells. Fixing a cellular sample allows for the sample to be washed to extract small molecules and lipids that may interfere with downstream analysis. Further, fixing and permeabilizing cells allows the cells to be stained with antibodies for surface proteins as well as intracellular proteins. Combined with the Reverse-Transcriptase polymerase chain reaction (RT-PCR) methods described herein, such staining can be used to achieve high levels of multiplexing because the antibodies are localized to the cell sample, while RT-PCR products are free within a microdroplet. Such a configuration allows for dyes of the same color to be used for antibodies and for amplicons produced by RT-PCR. Any suitable method can be used to fix cells, including but not limited to, fixing using formaldehyde, methanol and/or acetone. The cell may be coupled to an identifying tag. The tag may be optically (or chemically) activated to identify its presence and thereby denote presence (or absence) of a component of interest.
Referring again to
Processor circuitry 680 may comprise hardware, software or a combination of hardware and software (i.e., firmware). Processor circuitry 680 may comprise instructions to process signals received from electronic detector 680 and determine presence and movement of particles through microchannel 640. Once a detection component is identified through its emission frequency, its movement through the microchannel can be measured in relation to time to thereby provide an estimate of component's flowrate. To the extent that the detection component is associated with a cell, droplet or other particulate samples passing through the sampling area, the flowrate will be indicative of the sample through the microchannel.
Processor circuitry 680 may also comprise instructions that allows determination of non-movement (e.g., clogging) of the microchannel 640. Such instructions may be stored at memory circuitry 682 and executed on processor circuitry 680. In some embodiments, processor circuitry 640 may execute instructions to detect particle movement in microchannel 640 as slow as 1 μL/min or less. In another embodiment, the particle movement in microchannel 640 as slow as 1 μL/min or less. In still another embodiment, the particle movement may be at least 1 μL/min or higher. In yet another embodiment, detected particle movements of two or more particles may be measured by system 600. In an exemplary implementation, the movement may denote cell movement or migration across microchannel 640.
In an exemplary embodiment, processor circuitry 680 and memory circuitry 682 may comprise a comparator. The comparator can be configured to compare the detected flowrate with a threshold value to identify an obstruction in the microchannel. In another exemplary embodiment, the detected constituent flowrate is compared with a threshold value to identify internal pressure (or lack thereof) in the microchannel.
It will be apparent to those skilled in the technology of image displays that numerous changes and modifications can be made in the preferred embodiments of the invention described above without departing from scope of the invention. Accordingly, the foregoing description is to be construed in an illustrative and not in a limitative sense, the scope of the invention being defined solely by the appended claims.
The instant application claims priority to the filing date of Provisional Application No. 62/794,379, filed Jan. 18, 2019; the specification of which is incorporated herein in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2020/014488 | 1/21/2020 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62794379 | Jan 2019 | US |